$1.220
-0.057 (-4.69%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MXCT Prediction & Forecast by Similar Chart Analysis
Alphio's MXCT stock price prediction model matches the current MaxCyte Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.21 (-1.15%). The 1-week path is $1.18 (-3.01%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy MaxCyte Inc Stock?
MaxCyte Inc appears to be a good buy right now, trading at a current price of $1.22, which is significantly below the analyst price target of $5. The company's gross margin stands at a solid 63.86%, indicating strong profitability potential. However, the main risk is its negative net income, which was -8,874,000 USD in Q2 2026, reflecting ongoing financial challenges. Overall, the attractive valuation and growth prospects make it a compelling investment opportunity.
MXCT stock price ended at $1.22 on Friday, after losing -4.69%
MaxCyte Inc (MXCT) last closed at $1.22, losing -4.69%. These facts feed the 1-day and 1-week MXCT price prediction above.
Forecast Drivers
MaxCyte Inc (MXCT) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches MXCT, ranked by similarity.
Seasonality analysis for MXCT
Historically the probability of a positive August return for MXCT is 0.00%. January offers the highest probability of a positive month at 55.74%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MXCT
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.06 | $1.77 | $2.50 | +45.26% |
| Sep 2026 | $1.85 | $2.45 | $3.05 | +100.92% |
| Oct 2026 | $2.23 | $2.50 | $2.73 | +104.54% |
| Nov 2026 | $1.36 | $1.77 | $1.84 | +45.26% |
| Dec 2026 | $1.63 | $2.21 | $2.88 | +81.39% |
In 2026, MaxCyte Inc (MXCT) is projected to range from $1.06 to $3.05.
MaxCyte Inc 2026 monthly forecast
In Aug 2026, MaxCyte Inc is projected to average $1.77, with a low of $1.06 and high of $2.50.
In Sep 2026, MaxCyte Inc is projected to average $2.45, with a low of $1.85 and high of $3.05.
In Oct 2026, MaxCyte Inc is projected to average $2.50, with a low of $2.23 and high of $2.73.
In Nov 2026, MaxCyte Inc is projected to average $1.77, with a low of $1.36 and high of $1.84.
In Dec 2026, MaxCyte Inc is projected to average $2.21, with a low of $1.63 and high of $2.88.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.